We conducted a subgroup analysis focusing on PNS, which unveiled notable distinctions between patients exhibiting erythrocytosis and those without such syndromes regarding tumor size, albumin levels, and AFP levels (p < 0.001). The gene discussed is ALB; the disease is paraneoplastic neurologic syndrome.